DiscoverHeartBEATS from Lifelong Learning™hsCRP: Revolutionizing Cardiovascular Prevention and Treatment
hsCRP: Revolutionizing Cardiovascular Prevention and Treatment

hsCRP: Revolutionizing Cardiovascular Prevention and Treatment

Update: 2024-12-06
Share

Description

In this episode Dr. Paul Ridker discusses the pivotal role of high-sensitivity C-reactive protein (hsCRP), a biomarker for inflammation, in cardiovascular prevention and treatment. He explains how inflammation and cholesterol together drive atherosclerosis, the significance of hsCRP testing, and the latest clinical trial findings. Dr. Ridker also highlights the importance of primary prevention strategies and the potential of targeted anti-inflammatory therapies to revolutionize cardiovascular care.

Comments 
loading
In Channel
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

hsCRP: Revolutionizing Cardiovascular Prevention and Treatment

hsCRP: Revolutionizing Cardiovascular Prevention and Treatment

American Heart Association